Companies Dominating the Ibuprofen API Market
- Azelis
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Lonza
- BIOCAUSE Inc.
- IOL Chemicals and Pharmaceuticals Limited
- Granules India Limited
- SALVAVIDAS PHARMACEUTICAL PVT. LTD.
- Sri Krishna Pharmaceuticals Ltd.
- Taj Pharmaceuticals Limited
- Anantco Enterprises Pvt. Ltd.
- Wellona Pharma
Browse Key Market Insights with Data Illustration:
In the News
- September 19, 2022: Azelis, a prominent worldwide innovation service provider in the food additives and specialty chemicals sector, is pleased to announce that it has entered into a new distribution deal with the esteemed specialty chemical manufacturer Clariant. Customers of Azelis in Austria, Germany, and Switzerland now have instant access to the whole line of active pharmaceutical ingredients (API) and excipients from Clariant.
- March 8, 2022: At its active pharmaceutical ingredients (API) manufacturing facility in Nansha, China, Lonza, a global manufacturing partner to the biotech, nutrition, and pharmaceutical industries, today announced the completion of a laboratory expansion. With regard to the clinical supply of highly-potent APIs (HPAPI), the expansion primarily aimed to increase the capabilities and capacity of development laboratories and kilogram-scale cGMP manufacturing laboratories.
